FDA Wants to Relax Approval Process for Alzheimer's Drugs
THURSDAY, March 14 (HealthDay News) -- In an effort to quickly develop drugs that could prevent or slow Alzheimer's, the U.S. Food and Drug Administration said it plans to relax the approval process for experimental medications for the memory-robbing disease.
Tags:
FDA Wants to Relax Approval Process for Alzheimer's Drugs,
Food Latest News